Annular leukocytoclastic vasculitis associated with sorafenib administration.

Abstract Text

Only one case of vasculitis associated with sorafenib has been reported, and the authors now present the first reported case of annular leukocytoclastic vasculitis (LCV) linked to sorafenib administration.

Authors :-, , ,


Mesh Headings :-


Chemical List :-, , , , , , ,



2016-09-07 21:04:09

Click download button below to get the free Annular leukocytoclastic vasculitis associated with sorafenib administration. link to pdf of abstract on your facebook profile.

Download Server - Asia Download Server - America Download Server - Europe Download Server - Australia
Citation:- Najarian DJ, Packianathan DJ, Zeitouni DJ, .Annular leukocytoclastic vasculitis associated with sorafenib administration. Journal of drugs in dermatology : JDD 2010-Jun;9()697-8 DOI:



Details of Journal

Journal Title - Journal of drugs in dermatology : JDD

ISSN - 1545-9616

Volume - 9

Issue - 6

Publish date - 2010-Jun

Language - eng

Country - United States


SHARE PLEASE -
Read More Similar Articles

Isotretinoin as monotherapy for sebaceous hyperplasia.

Yu C, Shahsavari C, Stevens C, Liskanich C, Horowitz C, .Isotretinoin as monotherapy for sebaceous hyperplasia. Journal of drugs in dermatology : JDD 2010-Jun;9()699-701 DOI:.......

Read More

Pavicic T, Ruzicka T, Korting T, Gauglitz T, .Monophasic, cohesive-polydensified-matrix crosslinking-technology-based hyaluronic acid filler for the treatment of facial lipoatrophy in HIV-infected pat.......


ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report.

O'Neill J, Fien J, Zeitouni J, .ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report. Journal of drugs in dermatology : JDD 2010-Jun;9()688-9 DOI:.......

Read More

Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double-blind, placebo-controlled clinical trial.

Iraji F, Asilian F, Siadat F, .Pimecrolimus 1% cream in the treatment of cutaneous lesions of pemphigus vulgaris: a double-blind, placebo-controlled clinical trial. Journal of drugs in dermatology : J.......

Read More

Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions.

Brodmerkel C, Zhu C, Jiao C, Cornacoff C, Treacy C, Mascelli C, .Effects of ustekinumab administration on primate/human antigen-recall and humoral immune response functions. Journal of drugs in dermat.......

Read More

Vertical undermining for the closure of partial thickness surgical defects.

Vergilis-Kalner IJ, Mamelak IJ, Goldberg IJ, .Vertical undermining for the closure of partial thickness surgical defects. Journal of drugs in dermatology : JDD 2010-Jun;9()674-6 DOI:.......

Read More

Harnessing the anti-inflammatory effects of topical dapsone for management of acne.

Kircik LH, .Harnessing the anti-inflammatory effects of topical dapsone for management of acne. Journal of drugs in dermatology : JDD 2010-Jun;9()667-71 DOI:.......

Read More

The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review.

Patel M, Bowe M, Heughebaert M, Shalita M, .The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. Journal of drugs in dermatology : JDD 2010-Jun;9()65.......

Read More

Long-term efficacy and safety of topical PRK 124 (0.125%) lotion (Pyratine-XR) in the treatment of mild-to-moderate rosacea.

Tremaine AM, Ortiz AM, Elkeeb AM, Tran AM, Weinstein AM, .Long-term efficacy and safety of topical PRK 124 (0.125%) lotion (Pyratine-XR) in the treatment of mild-to-moderate rosacea. Journal of drugs .......

Read More

//google analytics script here